AptaBio Therapeutics Inc. (KOSDAQ:293780)
6,620.00
-280.00 (-4.06%)
Mar 9, 2026, 3:30 PM KST
AptaBio Therapeutics Market Cap
AptaBio Therapeutics has a market cap or net worth of 185.98 billion as of March 9, 2026. Its market cap has decreased by -6.76% in one year.
Market Cap
185.98B
Enterprise Value
175.20B
Revenue
3.44B
Ranking
n/a
PE Ratio
n/a
Stock Price
6,620.00
Market Cap Chart
Since June 12, 2019, AptaBio Therapeutics's market cap has decreased from 423.30B to 185.98B, a decrease of -56.06%. That is a compound annual growth rate of -11.48%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| REYON Pharmaceutical | 191.66B |
| JW Lifescience | 200.22B |
| Jeil Pharmaceutical Co.,Ltd | 210.56B |
| HLB Pharmaceutical | 212.04B |
| SAMSUNG PHARM. Co., LTD. | 175.44B |
| Hana Pharm | 174.00B |
| Daihan Pharmaceutical | 172.87B |
| Dongwha Pharm.Co.,Ltd | 171.02B |